XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS    
Product revenue $ 35,594,520 $ 31,084,953
Cost of goods sold 10,468,529 9,131,716
Gross profit 25,125,991 21,953,237
Operating expenses:    
Research and development, net of grant income 6,916,181 15,594,442
Selling, general and administrative 34,995,749 38,307,415
Total operating expenses 41,911,930 53,901,857
Loss from operations (16,785,939) (31,948,620)
Other income (expense):    
Interest expense, net (1,399,092) (157,891)
Gain (loss) on foreign currency transactions (4,224,721) 1,949,257
Miscellaneous income (expense) (30) 96,755
Total other income (expense), net (5,623,843) 1,888,121
Loss before benefit from income taxes (22,409,782) (30,060,499)
Benefit from income taxes 1,690,825 813,739
Net loss attributable to common stockholders $ (20,718,957) $ (29,246,760)
Net loss per common share attributable to common stockholders, basic $ (0.38) $ (0.65)
Diluted net loss per common share $ (0.38) $ (0.65)
Weighted average number of shares of common stock outstanding, basic 54,434,609 44,656,391
Weighted average number of shares of common stock outstanding, diluted 54,434,609 44,656,391
Comprehensive loss:    
Net loss $ (20,718,957) $ (29,246,760)
Other comprehensive income (loss):    
Foreign currency translation adjustment 4,027,003 (1,799,874)
Comprehensive loss $ (16,691,953) $ (31,046,634)